Insider · CIK 0002127888
Peter Ashley Marks
Files at ATHE (ALTERITY THERAPEUTICS LTD). First filing Sep 8, 2026, latest Sep 8, 2026.
In brief
Peter Ashley Marks files SEC Form 4 as director at ATHE (ALTERITY THERAPEUTICS LTD). Since Sep 8, 2026, Peter Ashley Marks has reported 1 open-market buy worth $24k and 0 open-market sells worth $0, the latest filed on Sep 8, 2026.
A track record needs three past buys with six months of prices behind them; Peter Ashley Marks has 0, so none is measured yet.
The newest scored trade: bought $24k of ATHE on Aug 31, 2026, filed Sep 8, 2026, scored 21 (weak). In the last 12 months: 1 buy worth $24k and 0 sells worth $0.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
ATHE: ALTERITY THERAPEUTICS LTD
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 21Weak | ATHEbuy ALTERITY THERAPEUTICS LTD | $24k 47,620 shares | +33% | - |
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 31, 2026 | ATHE ALTERITY THERAPEUTICS LTD | POpen-market purchase Ordinary sharesindirect: Lampam Pty Ltd | +47,620 | $0.50 | $24k | 191,340 | 35 d ago |
| Aug 31, 2026 | ATHE ALTERITY THERAPEUTICS LTD | POpen-market purchase Listed option exp 31 Aug 2026derivativeindirect: Lampam Pty Ltd | -47,620 | $0.50 | $24k | 0 | 35 d ago |
Questions about Peter Ashley Marks
Answered from the filings on this page, as of the latest one.
Is Peter Ashley Marks buying or selling?
In the last 12 months Peter Ashley Marks reported 1 open-market buy worth $24k and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $24k of ATHE on Aug 31, 2026. Grants, option exercises and tax withholding are not counted.
How did Peter Ashley Marks's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Peter Ashley Marks has 0.
Where does Peter Ashley Marks file Form 4?
Peter Ashley Marks has filed Form 4 at ATHE (ALTERITY THERAPEUTICS LTD). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.